MiMedx: Undisclosed Failed Inspections, Illegal Injections, and the FDA - Aurelius Value
This report specifically exposes severe undisclosed manufacturing problems and contamination risks. Even though FDA investigators identified issues that “pose a significant risk to the recipient”, the company is marketing unapproved products produced by these facilities for risky experimental indications such as spinal injections. Unsuspecting patients are being defrauded through false advertisements used by dubious clinics to entice them into receiving the injections. Because these activities appear to put patients in danger, we believe the FDA has no choice but to immediately intervene.